What happens when you quit Ozempic? New study sheds light
A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.
The more Americans who take Ozempic, the faster the US economy could grow, Goldman Sachs says
With the US obesity rate hovering at around 40%, tens of millions of Americans could take GLP-1 drugs over the next few years ...
Fidelity Diversified International Fund Q3 2024 Review
Fidelity Diversified International Fund is a broadly diversified international equity strategy that seeks capital growth by ...
Fidelity International Capital Appreciation Fund Q3 2024 Review
Fidelity International Capital Appreciation Fund is a diversified international equity strategy that seeks capital growth by ...
Zacks.com on MSN22h
Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate
Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...
The Oswegonian21h
As demand for Ozempic, Wegovy soars, patients who need them face barriers
As more Americans are prescribed weight loss drugs like Ozempic and Wegovy following celebrity endorsements, people who depend on such medications have struggled to access them. Sarah Sostak, a ...
China's JD.com misses revenue estimates as consumption weakness lingers
(Reuters) -Chinese e-commerce group JD.com missed market estimates for quarterly revenue on Thursday, as a persistent ...
pulmonologyadvisor1h
GLP-1 Drug Shortages: How Do They Affect Patients With Diabetes?
GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
Worldwide Healthcare Trust PLC - Half-year Report
Worldwide Healthcare Trust PLC - Half-year Report PR Newswire LONDON, United Kingdom, November 15 LONDON STOCK EXCHANGE ANNOUNCEMENTWorldwide Healthcare Trust PLCUnaudited ...